Page 20 - Read Online
P. 20

Kenneson et al. J Transl Genet Genom 2024;8:285-97  https://dx.doi.org/10.20517/jtgg.2024.22  Page 291

               Table 6. Visits to specialists in the previous year
                                Percentage who saw    Age of individuals who saw   Number of visits in the past year
                Specialist      specialists in the past year   specialists in the past year,   among those who saw specialists,
                                (95%CI)               median                 median (range)
                Cardiologist    97.9% (92.6%-99.4%)   13.4 years             3 (1-12+)
                Hematologist    58.2% (48.0%-67.8%)   19.6 years             2 (1-12+)
                Nutritionist/dietitian  57.2% (46.7%-66.8%)  19.8 years      1 (1-12+)
                Metabolic specialist  44.4% (34.6%-54.7%)  21.2 years        1 (1-12+)
                Gastroenterologist  27.5% (19.4%-37.4%)  17.4 years          1 (1-4)
                Neurologist     24.5% (16.0%-34.0%)   9.2 years              1 (1-6)
                Orthopedic specialist  23.0% (16.4%-33.6%)  10.4 years       1 (1-4)
                Endocrinologist  20.9% (13.8%-30.3%)  10.6 years             1 (1-4)
                Immunologist/allergy   16.8% (10.5%-26.0%)  12.7 years       1 (1-2)
                specialist
                Hepatologist    3.3% (1.1%-9.2%)      8.5 years              1 (1-2)





































                Figure 1. Proportion (and 95% confidence intervals) of individuals with BTHS who experience 1A) cardiac, 1B) neutropenia, and 1C) GI
                manifestations and use medications for those respective categories (1D-1F) by age group. Cardiac disorder was defined as
                cardiomyopathy, cardiac arrest, cardiac failure, or the presence of an implantable device. GI disorder was defined as constipation,
                chronic diarrhea, dysphagia, feeding difficulties, or gastroesophageal reflux. BTHS: Barth syndrome; GI: gastrointestinal.

               upon previous reports by including evaluations of manifestations by age, descriptions of manifestations that
               led to diagnosis, and assessment of levels of healthcare utilization.

               Diagnostic odyssey
               Our analysis showed similar results to previous studies of individuals with BTHS, wherein cardiomyopathy
               began in childhood, with the majority experiencing cardiomyopathy before the age of one year [16,25] . Analysis
               of the registry data indicated that diagnostic odysseys were often long, with slightly less than half of
               participants receiving a diagnosis within one year of onset of manifestation(s). Although a range of
   15   16   17   18   19   20   21   22   23   24   25